SCHEMBL6153679

SCHEMBL6153679

COc1cc(NC2CCNCC2)ccc1C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 2/20 0.48
KIT P10721 1/20 0.47
FLT3 P36888 1/20 0.47
PARP15 Q460N3 1/20 0.44
PARP10 Q53GL7 1/20 0.44
CDK1 P06493 1/20 0.44
CDK4 P11802 1/20 0.44
CCND1 P24385 1/20 0.44
CDK2 P24941 1/20 0.44
AURKA O14965 1/20 0.42
RPS6KB1 P23443 1/20 0.42
HTR6 P50406 2/20 0.42
TGFBR1 P36897 1/20 0.41
ACVR1 Q04771 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154140 0.95 HTR4 (0.45) HTR4KITFLT3PARP15PARP10
SCHEMBL6154287 0.87 PARP15 (0.55) KITFLT3PARP15PARP10SYK
SCHEMBL6154413 0.86 IRAK4 (0.48) MKNK1MKNK2
SCHEMBL6153513 0.86 SYK (0.46) KITFLT3PARP15PARP10CDK1
SCHEMBL6153579 0.86 KIT (0.60) KITFLT3PARP15PARP10MEN1
SCHEMBL6153341 0.86 KIT (0.60) KITFLT3PARP15PARP10MEN1
SCHEMBL6153345 0.86 KIT (0.60) KITFLT3PARP15PARP10MEN1
SCHEMBL6154097 0.85 FLT3 (0.53) FLT3AURKARPS6KB1SYK
SCHEMBL6153322 0.85 FLT3 (0.47) KITFLT3PARP15PARP10CDK4
SCHEMBL6154491 0.85 KIT (0.47) KITFLT3PARP15PARP10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 HTR4 2642/4885KIT 775/4885FLT3 2536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.